Transfusion and Haematology Today - Issue 4/2022
Review/Educational Papers
195
Tixagevimab-cilgavimab eff ectiveness in preexposure prophylaxis and therapy in patients at high risk of COVID-19
B. Weinbergerová, T. Kabut, J. Mayer
Original Papers
203
How do anti-SARS-CoV-2 IgG and IgM predict the titre of virus-neutralizing antibodies in donors of convalescent plasma against COVID-19 disease?
A. Entrová, K. Azeem, J. Vlčková, J. Smital, S. Zatloukalová, J. Ševčíková, H. Kollárová, D. Horáková
213
Current experience with ropeginterferon Alfa-2b in Ph negative myeloproliferative neoplasm at the Department of Internal Medicine – Haematology and Oncology in Brno
N. Podstavková, B. Weinbergerová, J. Procházková, M. Bohúnová, A. Marečková, J. Kotašková, I. Ježíšková, M. Doubek, J. Mayer
Case Report
221
Haemolytic disease of the foetus and new-born
H. Kostrouchová, J. Tylečková, R. Gerychová
228
Beta-thalassemia minor and maior in pregnancy
J. Racková, M. Mrázek
Letters to Editor
235
Personal News
Transfusion and Haematology Today
2022 Issue 4
Most read in this issue
- Haemolytic disease of the foetus and new-born
- Beta-thalassemia minor and maior in pregnancy
- Current experience with ropeginterferon Alfa-2b in Ph negative myeloproliferative neoplasm at the Department of Internal Medicine – Haematology and Oncology in Brno
- How do anti-SARS-CoV-2 IgG and IgM predict the titre of virus-neutralizing antibodies in donors of convalescent plasma against COVID-19 disease?